Humana Inc. (HUM) earnings
HUM earnings moved a median of -0.35% by the close. Quarterly and annual HUM reports and results, each read against the price at its own news timestamp. Back to the HUM overview →
28 measured HUM earnings events.
Where these HUM earnings landedvs 28 measured HUM earnings reactions
| Middle 50% of HUM earnings reactions | -3.40% to +1.14% |
|---|---|
| Median reaction (to close) | -0.35% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 HUM earnings events with a measured close landed between -3.40% and +1.14%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026 | Press release | +0.32% | -4.02% | |
| Form 10-Q HUMANA INC For: Jun 30 | SEC filing · Form 10-Q | -0.36% | +1.24% | |
| Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance | Press release | +0.25% | -5.87% | |
| Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026 | Press release | -0.52% | -0.77% | |
| Form 10-Q HUMANA INC For: Mar 31 | SEC filing · Form 10-Q | — | +2.52% | |
| Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance | Press release | -0.52% | +11.52% | |
| Humana Inc. to Release First Quarter 2026 Results on April 29, 2026 | Press release | -0.17% | +3.45% | |
| Form 10-K HUMANA INC For: Dec 31 | SEC filing · Form 10-K | — | -0.28% | |
| Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance | Press release | +3.81% | +2.57% | |
| Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026 | Press release | -0.49% | -0.94% | |
| Form 10-Q HUMANA INC For: Sep 30 | SEC filing · Form 10-Q | -0.29% | +1.11% | |
| Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance | Press release | -4.15% | -0.02% | |
| Humana Inc. to Release Third Quarter 2025 Results on November 5, 2025 | Press release | -0.32% | -3.30% | |
| Form 10-Q HUMANA INC For: Jun 30 | SEC filing · Form 10-Q | +0.49% | +0.78% | |
| Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance | Press release | +0.32% | +6.09% | |
| Humana Inc. to Release Second Quarter 2025 Results on July 30, 2025 | Press release | -0.58% | -1.01% | |
| Form 10-Q HUMANA INC For: Mar 31 | SEC filing · Form 10-Q | -4.25% | -4.95% | |
| Humana Reports First Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted Financial Guidance | Press release | -4.25% | -4.95% | |
| Humana Inc. Announces Dates for First Quarter 2025 Earnings and June Investor Conference | Press release | +0.87% | -3.73% | |
| Form 10-K HUMANA INC For: Dec 31 | SEC filing · Form 10-K | +0.06% | +1.00% | |
| Humana Reports Fourth Quarter 2024 Financial Results; Provides Full Year 2025 Financial Guidance | Press release | -0.59% | -5.45% | |
| Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025 | Press release | +1.49% | +0.39% | |
| Form 10-Q HUMANA INC For: Sep 30 | SEC filing · Form 10-Q | -0.30% | -0.86% | |
| Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance | Press release | +2.62% | +2.43% | |
| Humana Inc. to Release Third Quarter 2024 Results on October 30, 2024 | Press release | -1.95% | -11.29% | |
| Form 10-Q HUMANA INC For: Jun 30 | SEC filing · Form 10-Q | -0.36% | -0.42% | |
| Humana Reports Second Quarter 2024 Financial Results; Affirms Full Year Adjusted 2024 Financial Guidance | Press release | +1.50% | -0.93% | |
| Humana Inc. to Release Second Quarter 2024 Results on July 31, 2024 | Press release | +0.30% | +0.80% |
Keep exploring
More HUM: analyst actions → · SEC filings → · HUM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Clovis Oncology, Inc. (CLVS) | 1,349 | -0.20% | 47% |
| Merck & Company, Inc. (new) (MRK) | 1,319 | +0.02% | 51% |
| WELLCARE HEALTH PLANS (WCG) | 1,292 | 0.00% | 50% |
| Sorrento Therapeutics, Inc. (SRNE) | 1,269 | -0.27% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.